# Comparative Humoral Immune Responses Induced by Live-Attenuated and Inactivated Porcine Epidemic Diarrhea Vaccines in Replacement Gilts

**Authors:** Prapassorn Boonsoongnern, Orawan Boodde, Wilairat Chumsing, Pichai Jirawattanapong, Manakorn Sukmak, Yonlayong Woonwong, Narut Thanantong, Worawidh Wajjwalku, Alongkot Boonsoongnern

PMC · DOI: 10.3390/vaccines14030231 · Vaccines · 2026-02-28

## TL;DR

This study compares how two types of PED vaccines affect immune responses in pigs, finding that a combination of live and inactivated vaccines works best.

## Contribution

The study introduces a novel heterologous prime-boost vaccination strategy for PEDV that elicits stronger immune responses.

## Key findings

- The L/K regimen induced the highest PEDV-specific IgG responses compared to other groups.
- Serum-neutralizing antibody titers were significantly higher in the L/K and L/L groups.
- IgA responses were low and transient across all vaccination groups.

## Abstract

Background/Objectives: Porcine epidemic diarrhea (PED) is a highly contagious enteric disease caused by porcine epidemic diarrhea virus (PEDV) and is associated with severe clinical signs and high mortality in neonatal piglets. Vaccination is an important strategy for PED control through the induction of humoral immunity. This study aimed to compare immune responses induced by inactivated and live-attenuated PEDV vaccines and to evaluate a heterologous prime-boost vaccination strategy in PEDV-naïve replacement gilts. Methods: Twenty-four PEDV-naïve replacement gilts were randomly assigned to four groups: unvaccinated control, inactivated vaccine administered twice (K/K), live-attenuated vaccine administered twice (L/L), and live-attenuated priming followed by an inactivated booster (L/K). Pigs received two intramuscular vaccinations at 16 weeks of age and two weeks later. Serum samples collected up to 42 days post-vaccination were analyzed for PEDV-specific IgG and IgA antibodies by ELISA, and serum-neutralizing antibody titers were determined using a serum neutralization test. Results: The L/K regimen induced the highest PEDV-specific IgG responses, with peak levels at day 28 post-vaccination that were significantly higher than those in the K/K and control groups. Serum-neutralizing antibody titers were significantly higher in the L/K and L/L groups than in the K/K and control groups. Serum IgA responses were low and transient across all vaccination groups. Conclusions: A heterologous prime-boost vaccination strategy using a live-attenuated PEDV vaccine followed by an inactivated booster induces strong systemic humoral immune responses in replacement gilts and represents a promising approach for PEDV vaccination programs.

## Linked entities

- **Diseases:** PED (MONDO:0012805)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, IGHA (immunoglobulin alpha heavy chain constant region) [NCBI Gene 100568455] {aka IGA}
- **Diseases:** PED (MESH:D019318), dehydration (MESH:D003681), enteric disease (MESH:D004751), diarrhea (MESH:D003967), fever (MESH:D005334), infection (MESH:D007239), injury to (MESH:D014947), watery diarrhea (MESH:D003969)
- **Chemicals:** ethylenimine (MESH:C033132), carbonate (MESH:D002254), penicillin (MESH:D010406), CO2 (MESH:D002245), Tween-20 (MESH:D011136), bicarbonate (MESH:D001639), S (MESH:D013455), BEI (-), streptomycin (MESH:D013307), sodium thiosulfate (MESH:C017717), Polystyrene (MESH:D011137)
- **Species:** Sus scrofa (pig, species) [taxon 9823], Porcine reproductive and respiratory syndrome virus (no rank) [taxon 28344], Classical swine fever virus (no rank) [taxon 11096], Porcine epidemic diarrhea virus (no rank) [taxon 28295], African swine fever virus (no rank) [taxon 10497], Homo sapiens (human, species) [taxon 9606], Porcine circovirus 2 (no rank) [taxon 85708]
- **Cell lines:** MN379926 — Mus musculus (Mouse), Hybridoma (CVCL_G564), Vero — Chlorocebus sabaeus (Green monkey), Spontaneously immortalized cell line (CVCL_0059), CCL-81 — Homo sapiens (Human), Neoplasm, Cancer cell line (CVCL_M024)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13030667/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13030667/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC13030667/full.md

---
Source: https://tomesphere.com/paper/PMC13030667